Home/Filings/4/0001225208-16-034453
4//SEC Filing

WEST PHARMACEUTICAL SERVICES INC 4

Accession 0001225208-16-034453

$WSTCIK 0000105770operating

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:08 PM ET

Size

8.4 KB

Accession

0001225208-16-034453

Insider Transaction Report

Form 4
Period: 2016-06-02
Malone Daniel
Vice President & Controller
Transactions
  • Exercise/Conversion

    Common Stock

    2016-06-02$22.48/sh+3,950$88,81630,665.502 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2016-06-02$22.48/sh3,950$88,8160 total
    Exercise: $22.48From: 2008-02-27Exp: 2017-02-27Common Stock (3,950 underlying)
  • Sale

    Common Stock

    2016-06-02$74.95/sh3,950$296,05726,715.502 total
Footnotes (2)
  • [F1]The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $74.76 to $75.08, inclusive. The reporting person undertakes to provide to West PharmaceuticalServices, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate pricewithin the range in this footnote.
  • [F2]Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

Documents

1 file

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeoperating
IncorporatedPA

Related Parties

1
  • filerCIK 0000105770

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:08 PM ET
Size
8.4 KB